Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in CD4 + T cells resulted in chronic and severe interleukin-17A-mediated inflammation during Chlamydia pneumoniae lung infection, increased T helper 17 (Th17) cell formation in lungs of infected mice, accelerated atherosclerosis, and more severe experimental autoimmune encephalomyelitis. While RIP2 deficiency resulted in reduced conventional Th17 cell differentiation, it led to significantly enhanced differentiation of pathogenic (p)Th17 cells, which was dependent on RORa transcription factor and interleukin-1 but independent of nucleotide oligomerization domain (NOD) 1 and 2. Overexpression of RIP2 resulted in suppression of pTh17 cell differentiation, an effect mediated by its CARD domain, and phenocopied by a cell-permeable RIP2 CARD peptide. Our data suggest that RIP2 has a T cellintrinsic role in determining the balance between homeostatic and pathogenic Th17 cell responses.
In Brief
RIP2 is the key adaptor molecule for NOD1-and NOD2-mediated intracellular signaling to sense pathogens and cell activation in myeloid cells. Shimada, Porritt, and colleagues demonstrate a previously unappreciated role for RIP2 in Th17 cell regulation and differentiation in a T cell-intrinsic manner.
SUMMARY
Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in CD4 + T cells resulted in chronic and severe interleukin-17A-mediated inflammation during Chlamydia pneumoniae lung infection, increased T helper 17 (Th17) cell formation in lungs of infected mice, accelerated atherosclerosis, and more severe experimental autoimmune encephalomyelitis. While RIP2 deficiency resulted in reduced conventional Th17 cell differentiation, it led to significantly enhanced differentiation of pathogenic (p)Th17 cells, which was dependent on RORa transcription factor and interleukin-1 but independent of nucleotide oligomerization domain (NOD) 1 and 2. Overexpression of RIP2 resulted in suppression of pTh17 cell differentiation, an effect mediated by its CARD domain, and phenocopied by a cell-permeable RIP2 CARD peptide. Our data suggest that RIP2 has a T cellintrinsic role in determining the balance between homeostatic and pathogenic Th17 cell responses.
INTRODUCTION
T helper (Th) 17 cells and interleukin-17A (IL-17A) are now recognized as critically important players in various pathologies, both autoimmune and in responses to infections. Indeed, IL-17A plays a major role in colitis, cancer, psoriasis, experimental autoimmune encephalomyelitis (EAE), and numerous infection models (Patel and Kuchroo, 2015) . Th17 cells are normally induced by the presence of a combination of cytokines, such as transforming growth factor-b (TGF-b) and IL-6 (Veldhoen et al., 2006) . This ''conventional'' induction of IL-17A normally requires activation of the transcription factors RORgt, IRF4, and BATF among others, which in turn induce the Th17 cell program (Yosef et al., 2013) . Alternative induction of Th17 cells using cytokines such as IL-1b, IL-6, and IL-23 result in a more ''pathogenic'' Th17 (pTh17) cells (Ghoreschi et al., 2010) . While the frequency and distribution of these various types of Th17 cells are currently under intense investigation by many laboratories, there is still much to be learned in order to understand the impact of the various Th17 cell programs.
The receptor-interacting protein 2 (RIP2) kinase serves as the signaling adaptor protein for the NOD1 and NOD2 intracellular receptors that recognize peptidoglycan, a component of bacterial cell walls, and the muramyl dipeptide structure found in almost all bacteria (Girardin et al., 2003; Ogura et al., 2001) . Binding of the receptors by its ligands induces a signaling cascade that will result in NF-kB activation and subsequent downstream cytokine production (Girardin et al., 2003) . These pathways are present in many cell types, including myeloid cells and neutrophils. However, the role of RIP2 in T cells has been much less studied and unappreciated. Previous investigations into the role of RIP2 in Th1 cell and Th2 cell differentiation did not report any effect on these pathways (Fairhead et al., 2008; Hall et al., 2008) .
In a previous study, we identified RIP2 as a critical signaling molecule in directing immune responses to Chlamydia pneumoniae (CP) infection in mice (Shimada et al., 2009) . CP, an obligate intracellular bacterium, has been associated with chronic lung diseases, including chronic bronchitis, asthma, chronic obstructive pulmonary disease, and other chronic diseases such as multiple sclerosis, atherosclerosis, and Alzheimer's disease (Shimada et al., 2012) . CP clearance is impaired in Rip2 À/À mice in macrophages, leading to delayed bacterial clearance. We additionally observed a sustained chronic lung inflammation in these mice, despite eventual bacterial clearance, but the mechanisms driving this late inflammation are unknown.
In this study, we first investigated the mechanism driving chronic lung inflammation in Rip2 À/À mice observed upon CP
infection. Restimulation of draining lymph nodes from Rip2
À/À infected mice showed increased IL-17A and decreased interferon-g (IFN-g) production, suggesting a possible mechanism for the chronic lung inflammation. We found that naive Rip2 À/À T cells preferentially differentiated toward pTh17 cells in a T cell-intrinsic manner and this was IL-1b dependent. In contrast, Rip2 À/À T cells had reduced cTh17 cell differentiation.
This altered T cell differentiation was independent of NOD1 and NOD2. Gene expression data revealed that Rip2 À/À T cells expressed greater amounts of Rora and Il1r1 compared with WT T cells during pathogenic Th17 cell differentiation, but not under conventional (cTh17) cell conditions. RORa is an important transcription factor involved in Th17 cell differentiation (Yang et al., 2008) . In line with this, we found that the enhanced pTh17 cell differentiation of Rip2 À/À cells was RORa dependent. Overexpression of RIP2 in T cells led to a reduction in pTh17 cell differentiation while silencing of Rip2 resulted in an increase in Rora and greater pTh17 cell differentiation. Il17a
were completely protected from the chronic lung inflammation found in Rip2 À/À mice, confirming that excess IL-17A in Rip2
T cells is driving the late and sustained immune responses and inflammation. We also confirmed these results using a mouse model of atherosclerosis and an EAE model, both in which IL-17A plays a critical role in development of disease (Chen et al., 2010; J€ ager et al., 2009) . When Rag1 À/À mice received
Rip2
À/À T cells, we found a significantly accelerated atherosclerosis, as well as a more severe EAE phenotype. These results highlight a previously unappreciated role for RIP2 in Th17 cell regulation and differentiation in a T cell-intrinsic manner.
RESULTS

RIP2 Deficiency in T Cells Increases IL-17A Production
We previously reported that RIP2 deficiency impairs host immune responses against C. pneumoniae, resulting in delayed bacterial clearance, increased mortality, and a severe chronic lung inflammation (Shimada et al., 2009 ). The defective bacterial clearance and increased mortality are rescued by adoptive transfer of WT macrophages. However, we became interested in the development of chronic lung inflammation, despite eventual bacterial clearance. Upon further investigation, we found that lung CD4 + T cells from Rip2 À/À mice 21 days post infection (p.i.) produced more IL-17A upon restimulation ( Figure 1A ). Enhanced IL-17A production in Rip2 À/À mice was largely dependent upon CD4 + T cells, as other IL-17A-producing cells showed little to no increase in IL-17A production ( Figures 1B and S1A ). Additionally, there was no observed difference in the numbers of IL-17A-producing pulmonary type 3 innate lymphoid cells (ILC3s) between WT and Rip2 À/À mice 21 days p.i. (Figure S1B ).
While we did not observe any differences in the number of IL-17A-producing cells in the lung between WT and Rip2 À/À mice at day 0 or 5 days p.i. (Figure S1C ), we found an increase in IL-17A and a decrease in IFN-g production by restimulated mediastinal lymph node (MLN) cells harvested 5 days p.i. (Figure 1C) . Furthermore, we observed that MLN cells from infected Rip2 À/À mice produced more IL-17A and less IFN-g in a dosedependent manner with specific antigen (UV-killed CP, UVCP) stimulation ( Figure 1D ). These data strongly suggested that RIP2 deficiency skewed T cells to differentiate toward Th17 cells.
To determine whether or not this was a T cell-intrinsic effect, we isolated CD4 + T cells from spleens of infected WT and Rip2
mice, which were then co-cultured with UVCP-preloaded WT bone marrow dendritic cells (BMDCs). Rip2 À/À CD4 + T cells produced significantly more IL-17A and less IFN-g than WT (Figure 1E ). Since UVCP contains LPS, we also stimulated the T cells with LPS as a control, but did not observe any significant effect on IL-17A production between WT and Rip2 À/À ( Figure 1E ). (Ghoreschi et al., 2010) . We observed that CD4 + T cells that lacked Rip2 had reduced IL-17A production under cTh17 cell conditions yet enhanced IL-17A production under pTh17 cell conditions (Figures 2A-2C ). The opposing role of RIP2 in cTh17 cell and pTh17 cell conditions was evident by both the percent of cells that produced IL-17A and the concentration of IL-17A in the culture supernatant (Figures 2A-2C , and Nod1 À/À Nod2 À/À mice. Our data revealed no difference in cTh17 cell and pTh17 cell differentiation, indicating that the T cell-intrinsic effect of RIP2 was independent of NOD1 and NOD2 signaling ( Figure S2 ). To further investigate Data are representative of three independent experiments (n = 5-7 mice/group). Statistical analyses: Student's t test. *p < 0.05, **p < 0.01, ***p < 0.001. Results are represented as mean ± SEM. See also Figure S1 .
the T cell-intrinsic nature of the observed Th17 cell differentiation in Rip2 À/À T cells, we mixed and matched naive WT and
Rip2
À/À T cells with WT or Rip2 À/À antigen-presenting cells (APCs) under pathogenic Th17 cell differentiation conditions and found that the increased IL-17A production was unrelated to the genotype of the APCs; instead, it was only the T cell genotype that mattered ( Figure 2D ). We also investigated whether RIP2 deficiency altered T cell proliferation and indeed found that CD4 + T cells lacking Rip2 proliferated more than WT cells under pTh17 cell conditions ( Figure 2E ). Given the relationship between regulatory T (Treg) cells and Th17 cells, we investigated whether RIP2 deficiency affected Treg cell suppression activity and differentiation. Importantly, RIP2 deficiency did not alter Treg cell suppression function ( Figure 2F ) or the differentiation of Treg cells in vitro ( Figure 2G ). In addition to IL-17A, Th17 cells can also produce IL-17F, and the IL-17A and F heterodimer (Wright et al., 2007) . However, while we did not observe an increase in IL-17F production in Rip2 À/À T cells, there was an increase in the amount of heterodimer produced ( Figure 2H ). Taken together, both our in vitro and in vivo data demonstrate that RIP2 deficiency in CD4 + T cells leads to enhanced pTh17 cell differentiation and suggest that RIP2 plays a T cell-intrinsic role in downregulating pathogenic Th17 cells. Conversely, our in vitro data suggest that RIP2 deficiency has opposing effects on cTh17 cell differentiation, suggesting RIP2 may act as a balancing factor between the homeostatic and pathogenic roles of Th17 cells.
À/À mice develop a severe chronic lung inflammation during CP infection (Shimada et al., 2009 ) that is accompanied with increased IL-17A production ( Figure 1 ). However, the role of IL-17A in CP pathogenesis is not fully understood. A previous study did find a slight increase in CP IFUs early (day 4) during infection after administering IL-17A-neutralizing antibodies (Mosolygó et al., 2013) ; however, in that study it was not clear how efficient IL-17A neutralization was. In order to better understand whether IL-17A is required in host immune responses for CP and CPinduced pathology, we examined the role of IL-17A during CP lung infection using Il17a À/À mice. We did not find delayed bacterial clearance and there were no changes in lung bacterial burden 5 or 14 days p.i. ( Figure 3A ). Despite the lack of difference in bacterial burden found between WT and Il17a À/À mice, there was a reduction in inflammation in the lungs of Il17a À/À mice 14 days after CP infection ( Figures 3B and 3C ) as well as a reduction in the total number of cells in the lung 14 days p.i. ( Figure 3D ). Numerous studies have found that IL-17A plays a role in neutrophil recruitment during infection (Huang et al., 2004; Kelly et al., 2005; Ye et al., 2001 ). While we did not observe any defect in early (day 5) neutrophil recruitment in Il17a À/À mice during CP infection, we found that neutrophil numbers were significantly reduced 14 days p.i. (Figures 3E and S3 ) despite a similar bacterial burden ( Figure 3A ). CD4 + T cell recruitment was also decreased in Il17a À/À mice 14 days p.i. (Figures 3F and 3G ).
These data suggest that IL-17A is dispensable for host defenses against CP infection but instead mediates the later stages of CPinduced sustained lung inflammation. Our data suggest that RIP2 deficiency in CD4 + T cells enhances Th17 cell differentiation. Therefore, we hypothesized that RIP2 deficiency exacerbates IL-17A-mediated chronic inflammation in Rip2 À/À mice and is likely responsible for the severe chronic lung inflammation that we previously reported (Shimada et al., 2009 
mice had similar delayed bacterial clearance as Rip2 À/À mice, again indicating that IL-17A does not play a substantial role in controlling CP bacterial burden ( Figure 3J ). These observations clearly suggest that IL-17A is responsible for the pathogenesis of chronic lung inflammation we have observed in the Rip2 À/À mice during CP infection.
RIP2 Deficiency Enhances IL-17A-Dependent Atherogenesis
While our data show that IL-17A plays a critical role in CP infection induced chronic lung inflammation in Rip2 À/À mice, we sought to investigate whether RIP2 deficiency exacerbated another disease pathology associated with IL-17A, atherosclerosis (Butcher et al., 2012; Chen et al., 2010; Gao et al., 2010) .
In an initial study we transferred WT, Rip2 À/À , or Il17a
bone marrow into irradiated Ldlr À/À mice. After bone marrow reconstitution (8 weeks), the chimeric mice were fed a HFD for 12 weeks. The Rip2 À/À chimeric mice exhibited a significant increase in lesion size in the aortic sinus and aorta en face , despite a similar serum cholesterol concentration (data not shown). This increase was abrogated in the Il17a
However, this experiment did not rule out the possibility that RIP2 played a role in immune cells other than T cells. We therefore performed an adoptive transfer of WT, Rip2 À/À , or 4H ). Taken together, these data indicate that RIP2 deficiency in T cells leads to accelerated atherogenesis via IL-17A production.
RIP2 Deficiency in T Cells Enhances EAE Severity and Mortality
While IL-17A clearly plays a role in atherogenesis, atherosclerosis is a multifactorial inflammatory disease with many contributing factors. We therefore assessed whether the loss of Rip2 in T cells would exacerbate another well-studied disease model, EAE, which has a primary contribution from pTh17 cells (Ghoreschi et al., 2010) . In order to investigate the T cell-intrinsic effect of RIP2 deficiency, we adoptively transferred WT and Rip2 Figure 5A ), which led to a significant (p < 0.05) increase in mortality ( Figure 5B ). Thus, RIP2 deficiency in CD4 + T cells alone leads to a significantly more pathogenic EAE phenotype, confirming the T cellintrinsic role of RIP2 in pathogenic Th17 cell development.
RORa and IL-1b Mediate the Enhanced Pathogenic Th17
Cell Differentiation of RIP2-Deficient T Cells Rip2 À/À naive CD4 + T cells are prone to differentiate toward Th17 cells under pathogenic Th17 cell differentiation conditions (Figures 2A and 2B) . Consistent with this observation, we found that Il17a was indeed upregulated in these cells ( Figure 6A ). However, we did not observe any difference in Rorc transcript expression between WT and Rip2 À/À pTh17 cells ( Figure 6B ).
Instead, we observed increased expression of Rora in Rip2
À/À T cells ( Figure 6C ). In an effort to confirm our data, we silenced Rip2 expression using shRNA in naive CD4 + T cells. T cells silenced for Rip2 expression and differentiated under pathogenic Th17 cell conditions produced greater amounts of IL-17A and expressed significantly more Rora (Figures 6D and  6E ). RORa was recently described to be expressed in Th17 cells and act in synergy with RORgt to promote Th17 cell differentiation (Yang et al., 2008) . In addition to Rora mRNA expression, Rip2
À/À CD4 + T cells displayed more RORa protein expression than WT ( Figure 6F ). Importantly, RORa protein expression correlated with IL-17A production ( Figures 6G-6I ).
To corroborate these associations, we identified two RORa binding sites (CNS1, CNS2) in the Il17a locus and performed a ChIP assay using anti-RORa antibody. Under pathogenic Th17 cell skewing conditions, we found that RORa bound to CNS 1 and 2 4-to 8-fold higher, respectively, in Rip2 À/À CD4 + T cells compared with WT CD4 + T cells ( Figure 6J ).
To determine the contribution of RORa to RIP2-mediated regulation of IL-17A production, we performed siRNA-mediated silencing of Rora in Rip2 À/À CD4 + naive T cells differentiated under pTh17 cell conditions. We found reduced IL-17A production in Rip2 À/À cells treated with siRora compared with controls ( Figure 6K ). To confirm this, we performed another experiment in which we used siRNA to silence Rip2 and Rora, alone or in combination, in CD4 + naive T cells differentiated under pTh17 cell conditions. Indeed, we found that siRNAmediated silencing of Rip2 led to enhanced IL-17A production and importantly this was abrogated with the additional silencing of Rora ( Figure 6L ). Next, we assessed transcript expression of known factors involved in pTh17 cell differentiation. While we found no significant differences in Tbx21, Ifng, Il23r, Csf2, and Il10 between WT and Rip2 À/À T cells ( Figure 6M ), we observed a significant increase in Il1r1 in Rip2 À/À T cells (Figure 6M) . To determine whether RORa was responsible for the enhanced expression of Il1r1, we performed siRNA-mediated silencing of Rora in Rip2 À/À T cells differentiated under pTh17 cell conditions. We found that there was a substantial reduction in Il1r1 with Rora silencing ( Figure 6N ), indicating that the enhanced expression of RORa in Rip2 À/À T cells is responsible for increased IL-1 receptor 1 (IL-1R1) expression. These re- and PBMCs (H). Data are representative of two independent experiments (n = 4-5 mice/group). Statistical analyses: one-way ANOVA followed by Tukey's post hoc test (B, C, and E) or Student's t test (F-H). *p < 0.05, **p < 0.01. See also Figure S4 .
sults, which are consistent with published studies showing RORa regulation of IL-1R1, led us to further investigate the contribution of IL-1b signaling to the enhanced differentiation of Rip2 À/À pTh17 cells (Chung et al., 2009 Figures 6O  and 6P ). The addition of Anakinra, an IL-1R1 antagonist, during pTh17 cell differentiation also abrogated the difference in IL-17A expression ( Figure S5 ). These data indicate that IL-1b signaling is necessary for enhanced Rora-mediated pTh17 cell differentiation of Rip2 À/À CD4 + T cells. Taken together, our data suggest that RIP2 may function to suppress a RORa-IL-1b signaling positive feedback loop during pTh17 cell differentiation. Of note, while we observed that Rorc was not changed in pTh17 cells ( Figure 6B ), Rorc was significantly reduced in Rip2 À/À CD4 + T cells under cTh17 cell differentiation conditions ( Figure S6A) , with Rora displaying a reducing trend ( Figure S6B ). These data corroborate the reduction in cTh17 cell differentiation observed in Rip2 À/À T cells (Figures 2A and   2B ). Additionally, we observed that under cTh17 cell conditions, Rip2 À/À T cells also displayed a reduction in Tbx21, Ifng, Il23r, Il1r1, and Csf2, with no observed differences in Il10 ( Figures  S6C-S6H ). Overall our data suggest that the mechanism by which RIP2 deficiency leads to enhanced pathogenic Th17 cell differentiation is through RORa, but not RORgt, and that loss of RIP2 expression may conversely lead to a reduction in cTh17 cell formation. We next sought to investigate whether RIP2 also played a role in human Th17 cell regulation. We isolated human memory (CD4 + CD45RO + CCR6 + ) T cells and silenced Rip2 with shRNA. Rip2 silencing resulted in increased RORa and IL-17A production ( Figure S7A and S7B). Thus, it is likely that RIP2 also plays a similar role in human T cell biology.
RIP2 CARD Domain Suppresses Pathogenic Th17 Cell Differentiation and Rora Expression
Given that the lack of RIP2 leads to increased RORa, we hypothesized that RIP2 itself leads to pTh17 cell suppression and might be regulated during Th17 cell differentiation. We determined the expression of Rip2 mRNA under Th17 cell differentiation and found that Rip2 mRNA is significantly downregulated during pTh17 cell differentiation compared to a T cell stimulatory condition ( Figure 7A ). We next isolated IL-17A-producing CD4 + T cells from the lungs 21 days after CP infection and found that lung IL-17A-producing T cells had significantly less Rip2 than IFN-g-producing T cells ( Figure 7B ). These data suggested an inverse relationship between Rip2 and pTh17 cells. To investigate how RIP2 may be acting to regulate pTh17 cell differentiation, we investigated the contribution of the kinase activity of RIP2 to its function. We treated CD4 + T cells undergoing pTh17 cell differentiation with two different RIP2 kinase inhibitors. This resulted in no difference (GSK583) or a small suppression (OD36) of IL-17A production, indicating that the kinase domain is not required for RIP2 deficiencyenhanced Th17 cell differentiation ( Figure 7C ). To determine the domains of RIP2 required for its function, we performed overexpression of RIP2, RIP2 lacking its kinase activity (RIP2K47A), or RIP2 lacking its CARD domain (RIP2DCARD). While overexpression of RIP2 in naive CD4 + T cells led to a decrease in IL-17A production under pTh17 cell differentiation conditions ( Figure 7D ), overexpression of RIP2K47A had only a moderate effect on preventing pTh17 cell differentiation (Figure 7D) . In contrast, overexpression of RIP2DCARD was unable to inhibit pTh17 cell differentiation ( Figure 7D ), suggesting that the CARD domain was required for RIP2 to exert its effect. Consistent with our model, overexpression of just the RIP2 CARD domain led to a significant decrease in IL-17A production under pTh17 cell conditions ( Figure 7E ). Furthermore, treatment with a cell-permeable (Lim et al., 2015) RIP2 CARD peptide led to a dose-dependent decrease in pTh17 cell differentiation and a reduction in Rora expression ( Figures 7F and 7G ). These data therefore indicate that it is the CARD domain of RIP2, not its kinase domain, that mediates regulation of pTh17 cell differentiation. Overall, our data strongly suggest that RIP2 plays a T cell-intrinsic negative feedback role during pTh17 cell differentiation.
DISCUSSION
The serine and threonine kinase RIP2 is the key adaptor molecule for NOD1-and NOD2-mediated intracellular signaling to sense pathogens and cell activation in innate immune cells (Ogura et al., 2001) . In this study, we discovered that in addition to its innate immune signaling properties in myeloid cells, RIP2 also functions as a T cell-intrinsic repressor of pTh17 cell differentiation, and in its absence, T cells are preferentially polarized toward Th17 cells under pathogenic conditions. In contrast, the absence of Rip2 resulted in reduced Th17 cell polarization under conventional conditions. The consequences of this regulation are that in Rip2 À/À mice, the Th17 cell population may become exaggerated and lead to enhanced inflammation and a more pathogenic chronic inflammatory state. We observed that both in vitro and in vivo RIP2 deficiency in T-cells leads to enhanced pTh17 cell differentiation that was directly responsible for exacerbated chronic lung inflammation, enhanced atherosclerosis, and more severe EAE. Initial investigations into the role of RIP2 in T cells reported defects in Th1 cell differentiation and TCR signaling as a result of RIP2 deficiency (Chin et al., 2002; Kobayashi et al., 2002; Ruefli-Brasse et al., 2004) . However, later studies disputed these findings, thus making the role of RIP2 in T cells controversial (Fairhead et al., 2008; Hall et al., 2008; Nembrini et al., 2008 
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T cell. Finally, we found that the acceleration of atherogenesis in Rip2 À/À mice was completely abrogated with Il17a
T cells, indicating the critical role of IL-17A in the acceleration of atherosclerosis in Rip2 À/À mice.
In a recent study, RIP2 deficiency was found to have a suppressive effect on the EAE model of multiple sclerosis (Shaw et al., 2011) . EAE progression has been linked to IL-17A as the development of EAE was markedly suppressed in Il17a À/À mice (Komiyama et al., 2006) . While the data from Shaw et al. (2011) at first may seem contradictory to our findings, there is a technical pitfall in that EAE model requires Complete Freund's Adjuvant, which includes Mycobacterial peptidoglycan signaling through NOD1, NOD2, and RIP2. Thus, the results from this earlier study can be interpreted that NOD1-, NOD2-, and RIP2-deficient mice lack proper innate immune signaling for MOG immunization, hence the lack of or diminished EAE development, as mentioned by the authors themselves (Shaw et al., 2011) . Indeed, using a Rip2 À/À CD4 + T cell-specific model of EAE, we report a profound increase in disease severity and mortality compared with WT CD4 + T cells, highlighting the pathogenic nature of Rip2 À/À T cells.
In addition to CD4 + T cells, other IL-17A-producing cell populations exist; gd T cells, CD3 + iNK cells, lymphoid-tissue inducer (LTi)-like cells, and NK cells are important innate IL-17A-producing cells during autoimmune inflammation and infectious diseases (Miossec and Kolls, 2012) . Innate IL-17A-producing cells can induce epithelial cell secretion of granulopoietic factors such as G-CSF and CCL20, which can lead to neutrophil infiltration, which is crucial for effective and rapid control of pathogens such as Klebsiella pneumoniae, Staphylococcus aureus, and Candida albicans (Aujla et al., 2008; Huang et al., 2004; Ishigame et al., 2009 ). In our study, IL-17A was involved in the persistence and late recruitment of neutrophils during C. pneumoniae-induced chronic lung infection, possibly through Th17 cell-derived IL-17A leading to G-CSF production from stromal cells. IL-17A did not pay a role in bacterial clearance of CP infection, indicating that IL-17A is not involved in the initial host defenses against CP, which is an intracellular pathogen. On the other hand, in Escherichia coli acute pulmonary infection, Rip2 À/À mice had reduced IL-17A production from NK cells and gd T cells (Balamayooran et al., 2011) , indicating that RIP2-deficient cellular responses are distinguishable between acute and chronic infections.
Previous publications have found a link between gut microbiota and Th17 cell populations in mice (Ivanov et al., 2008) . However, our in vitro data using naive CD4 + T cells clearly revealed an intrinsic enhancement of Th17 cell differentiation, and more importantly, the adoptive transfer of naive CD4 + WT
and Rip2 À/À T cells into Rag1 À/À mice provides identical microbiota host milieus, suggesting that it is the Rip2 À/À T cell itself and not any other external factor that drives the Th17 cell enhancement.
Our data demonstrate that this T cell-specific role of RIP2 in Th17 cell differentiation is independent of the NOD1 and NOD2 signaling pathway, suggesting that RIP2 may be activated via an alternative method in T cells. Several publications implicate NOD1, NOD2, and RIP2 as involved in other pathways besides sensing bacterial peptidoglycan both in vitro and in vivo. Nod1 À/À Nod2 À/À BMDMs respond to endoplasmic reticulum stress inducers differently (Keestra-Gounder et al., 2016), and NOD2 interacts with the small GTPase RAC1 under actin disruption by cytochalasin D (Legrand-Poels et al., 2007) . Nod1
shown various phenotypes in non-bacterial infection studies, such as atherosclerosis (Levin et al., 2011) , myocardial infarction (Li et al., 2015) , and influenza virus infection (Lupfer et al., 2013) . Our data indicate some key mechanisms by which RIP2 mediates signaling in T cells. RORa, a Th17 cell transcription factor, was upregulated in Rip2 À/À pTh17 cells compared with WT cells. RORa was recently shown to be important in Th17 cell differentiation and to work in synergy with the transcription factor RORgt (Yang et al., 2008) . While we did not observe any difference in Rorc expression, we show that RORa is responsible for the enhanced Th17 cell differentiation and IL-17A production in Rip2 À/À cells under pathogenic conditions. Our data also indicate that the increased expression of IL-1R1 that we observed in Rip2 À/À CD4 + T cells under pathogenic conditions was dependent on RORa upregulation, consistent with a prior study that reported RORa regulates IL-1R1 expression (Yang et al., 2008) . Furthermore, our data also suggest that IL-1b signaling is required for enhanced Rora expression and pTh17 cell differentiation in Rip2 À/À CD4 + T cells. Taken together our findings indicate that RIP2 may function to suppress the RORa-IL-1b signaling positive feedback loop during pTh17 cell differentiation. IL-1b is generally considered to play a driving role in pathogenic Th17 cell development (Ghoreschi et al., 2010) . In two of our in vivo models, CP lung infection and atherosclerosis, IL-1b is known to be critically required for host immune responses or contribute to the pathology, respectively (Duewell et al., 2010; Shimada et al., 2011) . Additionally, we observed that under pTh17 cell conditions, CD4 + WT T cells downregulated Rip2 mRNA. The Rip2 locus contains putative RORa binding sites in both human (chr8: 90773142-90773155 and chr8: 90774710-90774723) and mouse (chr4: 16085940-16085952 and chr4: 16087688-16087700), suggesting that RIP2 expression may be regulated by RORa as an intrinsic negative feedback during Th17 cell differentiation.
It remains unclear how RORa is being upregulated in Rip2
T cells. Although RIP2 possesses serine and threonine kinase activity, the direct interaction of RIP2 and RORa is unlikely due to different subcellular compartmentalization. Indeed, overexpression of RIP2 lacking kinase activity did not significantly affect the inhibition of pTh17 cell differentiation. However, overexpression of RIP2 lacking the CARD domain lost its inhibitory activity for pTh17 cell differentiation, suggesting that the CARD domain was critical for this function. Indeed, the CARD domain alone was sufficient to inhibit Rora expression and pTh17 cell differentiation. Thus, it is likely that RIP2 mediates inhibition of Rora through its CARD domain, although it is not clear yet how RIP2 physically interacts with the binding partner(s). Our results identify a pathway that is a prime candidate for targeting therapeutically as it potentially selectively targets pTh17 cells, not homeostatic cTh17 cells. It is also possible that the cell-permeable RIP2 CARD peptide could, in addition to reducing pTh17 cell development, also boost cTh17 cells, which are beneficial and important for homeostasis (Stockinger and Omenetti, 2017) . Therapeutic use of cellpermeable RIP2 CARD may prove effective in the treatment of IL-17A-mediated inflammatory diseases while reducing unwanted side effects such as those observed in current anti-IL17A treatments, which arise by loss of homeostatic IL-17 functions. In addition to ab CD4 + T cells, gd T cells, which have high responsiveness to IL-1R1, can produce large quantities of IL-17A in response to IL-1b, and generally as an early response to infection. However, in our experimental CP infection model, we did not observe an increase in gd T cell IL-17A production. While we have not directly examined IL-1R1 expression on Rip2 À/À gd T cells, one possible explanation for this observation may be that the development and effector fate mapping of gd T cells mainly takes place in the thymus and not during cytokine differentiation. Furthermore, a recent study has shown that while RORgt was required for the development of IL-17-producing gd T cell subsets, RORa was dispensable for normal gd T cell function (Barros-Martins et al., 2016) . Nevertheless, since we have not tested these cells directly, the role RIP2 may play in gd T cell function will need to be determined in future studies.
The involvement of RIP2 in Th17 cell differentiation in a T cellintrinsic manner provides an important mechanism by which human chronic inflammatory diseases might be mediated. Additionally, the clear association of Rip2 polymorphisms in various human diseases begs further investigations into the mechanism of RIP2 Th17 cell regulation, thus identifying individuals who might be a greater risk for various chronic inflammatory diseases where increased IL-17A plays a detrimental role, such as chronic lung diseases, atherosclerosis, Crohn's disease, multiple sclerosis, and other chronic inflammatory diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
METHOD DETAILS
C. pneumoniae Infection Model and Analysis C. pneumoniae CM-1 (ATCC, Manassas, VA) was propagated in HEp-2 cells as previously described (Shimada et al., 2009 ). Age and sex matched (6-8-week-old male or female) mice were intratracheally infected with C. pneumoniae by inoculating 100 ml of PBS containing 1 3 10 6 IFU of the microorganism. inoculation. Mice were euthanized 5, 14, 21 or 35 days post infection for analysis, as indicated. To quantify C. pneumoniae progeny in the lung, the inferior and post-caval lobes were homogenized with 1ml of sucrose-phosphate-glutamate medium. HEp2 cells were inoculated with lung specimens or cell lysates and bacterial counts determined as previously described using the Pathfinder Chlamydia Culture Kit (Shimada et al., 2009 ). For analysis of lung pathology, the left lung was fixed in formalin buffer, paraffin-embedded, and hematoxylin and eosin (H&E)-stained sections were scored by a trained pathologist blinded to the genotypes as previously described (Shimada et al., 2009 ). For analysis of lung lymphocyte populations; lymphocytes were isolated by digesting the superior and middle lobes at 37 C for 20 min in HANKS buffer containing 40 U/mL Liberase and 50 U/mL DNase1 then filtered through a 70 mm cell strainer followed by RBC lysis. For assessment of lung lymphocyte populations, flow cytometry was performed as described in Flow Cytometry below. For assessment of MLN cell cytokine expression at 21 days post infection, 2x10 5 lymph node cells were stimulated with plate bound anti-CD3 and anti-CD28, UV-killed C. pneumoniae (MOI 5, unless otherwise indicated) or LPS (100 ng/mL). The supernatants were collected on day 3 post stimulation and production of IFN-g and IL-17A were measured by ELISA. For analysis of cytokine production by splenic CD4 + T cells, spleens were harvested at day 5 post infection and CD4 + T cells were isolated with a mouse CD4 + T cell isolation kit (Miltenyi Biotec). CD4 + T cells were co-cultured with BMDCs pre-loaded with UVCP (MOI 5) or stimulated with LPS (100 ng/mL). Supernatants were collected on day 3 of culture and production of IFN-g and IL-17A were measured by ELISA. Cell culture was performed at 37 C in 5% CO 2 . (5x10 6 ) i.v. 6 weeks after transplant, mice were fed a HFD for 12 weeks then euthanized for analysis. The aortas were dissected and the adherent (adventitial) fat was gently removed. Whole aortas were opened longitudinally from the aortic arch to the iliac bifurcation, mounted en face, and stained for lipids with Oil Red O. Hearts were embedded in OCT (Tissue-Tek; Sakura, Torrance, CA) and serial 7 mm-thick cryosections from the aortic sinus were mounted and stained with Oil Red O and hematoxylin. Image analysis was performed by a trained observer blinded to the genotype of the mice. Representative images were obtained and lesion areas were quantified with Image analysis software using a BZ-X710 microscope (Keyence, Itasca, IL). The lesion area and lipid-stained area were measured as previously described (Tumurkhuu et al., 2016) . Blood was collected by retro-orbital bleed with Heparinized Hematocrit Tubes. Serum was separated by centrifugation and IL-17A expression in serum was measured by ELISA. PBMCs and spleen cells were analyzed by flow cytometry for IL-17A expression as described in Flow Cytometry below.
Atherosclerosis Model and Analysis
Experimental Autoimmune Encephalomyelitis (EAE) Model
Age matched 10-12-week-old Rag1 À/À female mice were adoptively transferred with WT or Rip2 À/À CD4 + T cells (2-3 3 10 6 cells) that were isolated from age matched female mice using a CD4 + T cell Isolation kit (STEMCELL EasySep kit). The next day EAE was induced using MOG and Complete Freund's Adjuvant (CFA) Emulsion Pertussis Toxin (PTX) kit (Hooke Laboratories) according to manufactures instructions. EAE clinical symptoms were blindly scored daily from day 7 -26 after MOG 35-55 immunization according to EAE scoring guidelines (Hooke Laboratories).
CD4 + T cell Differentiation and Treatment
Naive CD4 + T cells were isolated from the spleen of age and sex matched 6-10-week-old mice (STEMCELL EasySep kit). Cells were plated into plates coated with anti-CD3 and anti-CD28 in the presence of human rTGF-b (10 ng/mL) and mouse rIL-6 (20 ng/mL) for conventional Th17 cells or mouse rIL-1b (40 ng/mL), mouse rIL-6 (20 ng/mL) and mouse rIL-23 (50 ng/mL) for pathogenic Th17 cells in the presence of anti-mouse IFN-g (10 mg/mL) and anti-mouse IL-4 (5 mg/mL). For iTreg cell differentiation, naive CD4 + T cells were cultured with plate-bound anti-CD3 and anti-CD28 antibodies and recombinant TGF-b (5 ng/mL). For experiments analyzing cytokine expression by ELISA, supernatant was collected on day 5. Cells were analyzed on day 3 for intracellular cytokine expression, RORa expression or FOXP3 expression as detailed in Flow Cytometry below. For experiments analyzing gene expression by qPCR, cells were harvested on day 3. For dNP2-FLAG (control) and dNP2-CARD-FLAG (RIP2 CARD) peptide treatment of pTh17 cells, 15 mM or indicated dose of peptide was added at day 0 and day 2 of differentiation. On day 3 cells were either harvested for RNA extraction and qPCR or analyzed by flow cytometry for IL-17A expression. For treatment of cells with RIP2 Kinase inhibitors, cells were treated with OD36 (200 nM) or GSK583 (20 nM) at day 0 and day 2 of differentiation and analyzed on day 3 by flow cytometry for IL-17A expression. All cell culture was performed at 37 C in 5% CO 2 .
Generation of Bone Marrow Dendritic Cells (BMDC)
Bone marrow cells were cultured in the presence of rGM-CSF (20 ng/mL) to differentiate to BMDC. Media and cytokines were replenished at day 3 and day 6. Cells were harvested at day 10 and further isolated using the CD11c + isolation kit (Miltenyi Biotec). Cell culture was performed at 37 C in 5% CO 2 .
Co-culture of CD4 + T cells with BMDC CD4 + T cells were isolated from the spleen with a mouse CD4 + T cell isolation kit (Miltenyi Biotec). CD4 + T cells were co-cultured with BMDC at a ratio of 10:1 under pTh17 cell differentiation conditions. Supernatants were collected on day 3 of culture and production of IFN-g and IL-17A were measured by ELISA. Cell culture was performed at 37 C in 5% CO 2 . siRNA mediated gene silencing Naive CD4 + T cells were plated onto anti-CD3 and anti-CD28 coated plates with 12.5 ng/mL mouse rIL-2, anti-IFN-g (10 mg/mL) and anti-IL-4 (5 mg/mL) for 16-18 hours (culture media: IMDM with 10% FBS). Media was then removed and replaced with Accell Delivery Medium (Dharmacon) containing 10% delipidated FBS and cells were differentiated under pathogenic Th17 cell conditions with the addition of 1.5 mM of Accell control siRNA or siRNA targeted to murine siRora and/or siRip2 (Dharmacon). After 48 hours; culture media was replaced with fresh pTh17 cell condition media (IMDM containing 5% FBS). Next day, cells were harvested for qPCR or analyzed by flow cytometry for IL-17A expression.
Treg cells suppression assay
Retrovirus production and T cell transduction
The sequence encoding human RIP2 from the pUNO1-hRIPK2 vector was cloned into pMIGR1(EGFP) to generate pMIGR1-RIP2. From this plasmid, the change-IT Mutagenesis kit was used to generate pMIGR1-RIP2DCARD (RIP2 CARD domain deletion (1-143)), pMIGR1-RIP2K47A (RIP2 K47A mutation) and pMIGR1-RIP2.CARD (RIP2 CARD domain only). Rip2 shRNA (TRCN0000022485) was cloned into pMKO.1(-GFP) to generate pMKO.1-RIP2sh. Plasmids and pVSV-G were co-transfected into GP2-293 cells (Clonetech) with lipofectamine (Invitrogen). Retrovirus containing culture supernatant was collected at 48 hr and 72 hr post transfection. Naive CD4 + T cells were activated with anti-CD3 and anti-CD28 in the presence of 12.5 ng/mL mouse rIL-2, anti-IFN-g and anti-IL4 for 24 hours prior to retroviral infection. T cells were infected with retrovirus by centrifugation on RetroNectin (Takara) coated plates at varying multiplicities of infection (MOI). T cells were then cultured under pathogenic Th17 cell conditions. Retrovirus infected cells were sorted by GFP expression for qPCR analysis. Transduced T cells (GFP + ) were analyzed by flow cytometry for cytokine expression as detailed in Flow Cytometry.
Flow Cytometry Analysis
Flow cytometric analysis was performed on a LSR II (BD Biosciences) or a CyAn ADP Analyzer (Beckman Coulter, Inc.) and the data was analyzed by Summit (Dako, Carpentaria, CA, USA) or FlowJo (FlowJo, LLC, Ashland, OR). Flow sorting was performed on an Aria II or Aria III flow sorter (BD Biosciences). Anti-RORa was purchased from Abcam and conjugated with a FITC labeling kit (Thermo Fisher Scientific). All other antibodies were purchased from BioLegend, eBiosciences or TONBO as indicated in the Key Resource Table. For analysis of lung lymphocyte cytokine expression, cells were stimulated ex vivo with plate bound anti-CD3 and anti-CD28 for 24 hours in the presence of 3 mg/mL Brefeldin A, then stained for surface antigens to detect CD8 
Thy1
.1 + ), lung lymphocytes were stimulated with 50 ng/mL PMA and 1 mg/mL Ionomycin with 10 mg/mL Brefeldin A for 5-6 hours, stained for surface antigens then fixed, permeabilized (BD) and stained for IL-17A. For analysis of PBMC and spleen cell cytokine expression, cells were re-stimulated ex vivo with 50 ng/mL PMA and 1 mg/mL Ionomycin with 10 mg/mL Brefeldin A for 5-6 hours, stained for surface antigens to detect CD8 + and CD4 + T cells then fixed, permeabilized (BD) and stained for IL-17A. For analysis of lung neutrophil and T cell populations; cells were stained for surface antigens CD11b, Ly6G, CD3, CD4 and CD8. For assessment of cytokine production by in vitro derived Th17 cells, cells were stimulated with 50 ng/mL PMA and 1 mg/mL Ionomycin with 10 mg/mL Brefeldin A for 4 hours then stained for CD4 and a LIVE/DEAD fixable cell stain (Invitrogen). Cells were then fixed and permeabilized (BD) and stained for IL-17A. 
Il17a
EGFP reporter mice were treated with PMA (50 ng/mL) and Ionomycin (1 mg/mL) with 10 mg/mL Brefeldin A for 3 hours and stained with CD3, CD4 and Thy1.1 specific antibodies. For isolation of retrovirus infected cells for qPCR, cells were sorted based on GFP expression. For some experiments counting beads were added for calculation of cell numbers.
qPCR qPCR was performed with SYBR green system (Bio-Rad) or the Power SYBR Green RNA-to-Ct 1 step kit (Thermo Fisher Scientific). qPCR was performed for 18S, Csf2, Hprt, Ifng, IL10, Il17a, Il1r1, Il23r, Rip2 , Rora, Rorc and Tbx21 with primers listed in the Key Resource Table. ChIP assay ChIP assay was performed according to the manufacture's protocol of ChIP-IT High Sensitivity (Active Motif). Briefly, 7x10
6 in vitro differentiated pathogenic Th17 cells were cross-linked with 1% formaldehyde, then chromatin was sheared by sonication for 25 min (cycle of 30 s on, 30 s off). Chromatin was incubated with 4 mg of anti-RORa (ab60134, Abcam) or control rabbit IgG overnight at 4 C and then incubated with pre-washed protein G agarose beads for 3 hr. ChIP reactions were spun 1250 x g for 1 min, washed three times and immunoprecipitated DNA was purified. Il17a CNSs were analyzed by RT-PCR with SYBR green system (Bio-Rad) using primers for Il17a CNS1 and Il17a CNS2 listed in the Key Resource Table. shRNA mediated silencing of RIP2 in Human CD4 + T cells Peripheral Blood Mononuclear Cells (PBMC) were isolated using Ficoll-Paque PLUS gradient (GE Healthcare). CD4 + T cells were isolated using Dynal CD4 Positive Isolation Kit (Invitrogen). Purified cells were cultured in RPMI media containing 10% FBS and activated with anti-CD3 and anti-CD28 coated beads (Invitrogen) at a bead: cell ratio of 1:4 in media containing human rIL-2. VSV-G pseudotyped control or RIP2-shRNA (Sigma) containing viral particles were produced in HEK293T cells by calcium phosphate transfection according to the manufacturer's protocol (ProFection, Promega). Lentiviral supernatants were filtered, concentrated by centrifugation and filtered as previously described (Unutmaz et al., 1999) . Cells were infected with lentiviral supernatants (at multiplicity of infection, MOI, of 5) at day 1 of activation. For intracellular cytokine staining, cells were activated with PMA (20 ng/mL for CD4 + T cells and 40 ng/mL for PBMC) and Ionomycin (500 ng/mL) (Sigma Aldrich) in the presence of GolgiStop protein transport inhibitor (BD) for 4-6 hours. Cells were then stained for surface antigens CD3, CD4, CCR6 and CD45RO, then fixed and permeabilized (ebioscience) and stained for IL-17A. Immunoblot analysis was performed with anti-RIP2 (Abcam) and anti-RORa (Abcam) antibodies.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses of data are described in figure legends.
